• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS COBAS TAQSCREEN MPX TEST V2; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GROUP M AND O RNA, HIV-2 RNA, HCV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS COBAS TAQSCREEN MPX TEST V2; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GROUP M AND O RNA, HIV-2 RNA, HCV Back to Search Results
Catalog Number 05969484190
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/16/2019
Event Type  Injury  
Manufacturer Narrative
Medical opinion indicated that a (b)(6) nat would not prohibit the use of autologous stem cell products in the us; however, the institution's policy with regards to storage and distribution of such products or what the clinician would do is up to them.Although requested, it is unknown what decision was made for the affected autologous stem cell donor.There may be a potential delay in treatment pending further evaluation of the patient's infection status.However, no harm has been indicated to date.No issues were identified with the complaint kit lot during the investigation.The product common name was truncated and the complete name is "human immunodeficiency virus type 1 (hiv-1) group m rna, hiv-1 group o rna, human immunodeficiency virus type 2 (hiv-2) rna, hepatitis c virus (hcv) rna and hepatitis b virus (hbv) dna assay".(b)(4).
 
Event Description
A customer alleged a potential (b)(6) result while using the cobas taqscreen mpx test v2.An autologous stem cell donor obtained a (b)(6) with the cobas taqscreen mpx test v2 on (b)(6) 2019.This donor has tested (b)(6) with 3 collections in the previous 6 months ((b)(6) 2018, (b)(6) 2018, (b)(6) 2019), and 1 new collection ((b)(6) 2019).The donor was serology (b)(6).No harm has been indicated to date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS TAQSCREEN MPX TEST V2
Type of Device
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GROUP M AND O RNA, HIV-2 RNA, HCV
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS
1080 us hwy 202 s
branchburg NJ 08876
Manufacturer Contact
stacie-ann creighton
1080 us hwy 202 s
na
branchburg, NJ 08876
9082537112
MDR Report Key8508696
MDR Text Key141749489
Report Number2243471-2019-00016
Device Sequence Number1
Product Code MZF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date02/29/2020
Device Catalogue Number05969484190
Device Lot NumberE10662
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/14/2019
Initial Date FDA Received04/12/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age4 YR
-
-